Robotic Lung Biopsy Market Set to Surge, Expected to Exceed USD 1,023.05 Million by 2033 at a 9.6% of CAGR

Robotic Lung Biopsy Market

The global robotic lung biopsy market is on track for remarkable growth, projected to reach USD 408 million in 2023 and expand at a robust 9.6% CAGR through 2033. By the end of this forecast period, the total market valuation is expected to surpass USD 1.023 billion, driven by advancements in robotic-assisted diagnostic tools and the rising demand for minimally invasive procedures.

Key Factors Driving Market Growth

Several trends are fueling the rapid expansion of the robotic lung biopsy market:

• Increasing Demand for Minimally Invasive Procedures: Robotic lung biopsy offers a less invasive, precise alternative to traditional lung biopsy methods, leading to faster recovery and reduced patient discomfort.
• Technological Advancements in Robotic Diagnostics: Improvements in robotic systems and imaging technology are enhancing procedural accuracy and expanding the range of lung lesions that can be biopsied.
• Growing Incidence of Lung Cancer and Respiratory Disorders: As the global prevalence of lung cancer and other pulmonary conditions rises, demand for early and accurate diagnostic tools like robotic lung biopsy systems is increasing.

Future Market Insights’ analysis highlights the robust growth potential within the robotic lung biopsy market, which is anticipated to transform diagnostic capabilities in pulmonary care. With the projected surge in market value, the industry is poised for continued innovation, offering substantial benefits to healthcare providers and patients alike.

2018 to 2022 Robotic Lung Biopsy Sales Outlook Compared to Demand Forecast from 2023 to 2033

From 2018 to 2022, the global robotic lung biopsy market experienced a CAGR of 11.2% CAGR. Total market value at the end of 2022 reached around US$ 379.7 million.

From 2018 to 2022, the global robotic lung biopsy industry witnessed steady growth due to the rising demand for lung cancer control systems. The market for robotic lung biopsies was just getting started at the time, and adoption rates were quite low.

Due to their high price, limited availability, and the perceived risk associated with robotic surgery, many healthcare professionals were reluctant to invest in these systems.

As per estimates from Intuitive Surgical in 2022, a total of 321 Ion end luminal systems were installed globally.

Looking ahead, the global robotic lung biopsy industry is expected to progress at a CAGR of 9.6% from 2023 to 2033. By the end of 2033, the market size is expected to reach US$ 1,023.05 million.

Rising cases of lung cancer and shift towards minimally invasive procedures are key factors that are expected to drive the global market forward.

Key Companies Profiled

Ethicon, Inc. (Johnson & Johnson); Intuitive Surgical.

Get Complete Full Report

Robotic Lung Biopsy Market Segmentation

By Product and Services:

• System
• Instruments and Accessories
• Service

By Navigation Technology:

• Electromagnetic and Optical Navigation
• Fiber Optic RealShape Navigation

By End User:

• Hospitals
• Ambulatory Surgical Centers

By Region:

• North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East & Africa

Author By:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube